Correction: Targeted Oral Delivery of Paclitaxel Using Colostrum-Derived Exosomes (Cancers, (2021), 13, 15, (3700), 10.3390/cancers13153700)

Raghuram Kandimalla, Farrukh Aqil, Sara S. Alhakeem, Jeyaprakash Jeyabalan, Neha Tyagi, Ashish Agrawal, Jun Yan, Wendy Spencer, Subbarao Bondada, Ramesh C. Gupta

Research output: Contribution to journalComment/debate

Abstract

In the original publication [1], there was a mistake in the legends for Tables 1 and 2. The original table legends in the article indicated the doses of PAC, ExoPAC, and FA-ExoPAC as 8 mg/kg; however, the correct dosage was 9 mg/kg. The correct legends appear below. Correct Table 1 legend: Female C57BL/6 mice (5–6 weeks old) were provided control diet (AIN 93M) and water ad libitum and treated with colostrum-derived exosomes (60 mg/kg, b. wt.) by oral gavage, i.p. PAC (9 mg/kg) and ExoPAC and FA-ExoPAC (9 mg/kg PAC and 60 mg/kg exosome) for 28 days, three times a week. At euthanasia, blood was collected and analyzed using an automated AU640 Chemistry Analyzer by Antech diagnostics. Data represent average ± SD of four animals. Statistical analysis was performed using the Student t-test. Asterisks represent comparison to control while # represents a comparison to PAC group. *, p-value < 0.05; **, p < 0.01; ***, p < 0.001; #, p-value < 0.05; ##, <0.01. Correct Table 2 legend: Female wild-type C57BL/6 mice (5–6 weeks old) were provided control diet (AIN 93M) and water ad libitum and treated with colostrum-derived exosomes (60 mg/kg, b. wt.) by oral gavage, i.p. PAC (9 mg/kg) and ExoPAC and FA-ExoPAC (9 mg/kg PAC and 60 mg/kg exosome) for 28 days, three times a week. At euthanasia, blood was collected and analyzed using an automated AU640R Chemistry Analyzer by Antech diagnostics. Data represent average ± SD of four animals. Statistical analysis was performed using the Student t-test. *, p < 0.05; **, p < 0.01; ***, p < 0.001 in comparison to control group. #, p < 0.05 and ##, p < 0.01 in comparison to PAC group. In the original publication [1], there was a mistake in Figure 1B as published. The figures in panel B (FA-Exo and FA-ExoPAC) were the same. The corrected Figure 1 appears below. The authors apologize for any inconvenience caused and state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Original languageEnglish
Article number2955
JournalCancers
Volume17
Issue number18
DOIs
StatePublished - Sep 2025

Bibliographical note

Publisher Copyright:
© 2025 by the authors.

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Correction: Targeted Oral Delivery of Paclitaxel Using Colostrum-Derived Exosomes (Cancers, (2021), 13, 15, (3700), 10.3390/cancers13153700)'. Together they form a unique fingerprint.

Cite this